Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

CLO26-092: Real-World Use of Eflapegrastim in 14-Day Chemotherapy Cycles/Dose-Dense Regimens.

Journal of the National Comprehensive Cancer Network : JNCCN·2026

Same author

CLO26-092: Real-World Use of Eflapegrastim in 14-Day Chemotherapy Cycles/Dose-Dense Regimens.

Journal of the National Comprehensive Cancer Network : JNCCN·2026

Same author

Safety and efficacy of same-day administration of eflapegrastim in patients with early-stage breast cancer receiving chemotherapy.

The oncologist·2025

Same author

Potential role of perceived discrimination and sociodemographics on racial disparities in breast cancer symptom burden.

Journal of the National Cancer Institute·2025

Same author

Integrating a Rare Disease into Practice: Development of a Toolkit for Systemic Mastocytosis.

Journal of the advanced practitioner in oncology·2025

Same author

Patient and Advanced Practitioner Perspectives on Symptom Burden and Symptom Management in Indolent Systemic Mastocytosis.

Journal of the advanced practitioner in oncology·2025

Search research articles

Related Experiment Video

Updated: Nov 17, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

Biomarker BINGO.

Lauren Held¹, Sandra Kurtin², Lee Schwartzberg³

¹Seattle Cancer Care Alliance, Seattle, Washington.

Journal of the Advanced Practitioner in Oncology

|February 18, 2021

Summary

This session assessed knowledge of biomarkers for targeted cancer therapy. It covered key assays and guideline-recommended testing strategies for various tumor types.

Area of Science:

Oncology
Molecular Diagnostics
Clinical Pathology

Background:

Biomarker testing is crucial for precision medicine in oncology.
Identifying specific biomarkers guides the selection of targeted therapies.
Adherence to testing guidelines ensures optimal patient care.

Purpose of the Study:

To evaluate understanding of biomarker applications in targeted cancer therapy.
To assess knowledge of common biomarker assays.
To review guideline-recommended biomarker testing strategies.

Main Methods:

A knowledge-testing session format was employed.
Content focused on biomarker identification and targeted therapy selection.
Discussions included relevant diagnostic assays and clinical guidelines.

More Related Videos

A Combinatorial Single-cell Approach to Characterize the Molecular and Immunophenotypic Heterogeneity of Human Stem and Progenitor Populations

A Combinatorial Single-cell Approach to Characterize the Molecular and Immunophenotypic Heterogeneity of Human Stem and Progenitor Populations

Published on: October 25, 2018

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

Related Experiment Videos

Last Updated: Nov 17, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

A Combinatorial Single-cell Approach to Characterize the Molecular and Immunophenotypic Heterogeneity of Human Stem and Progenitor Populations

A Combinatorial Single-cell Approach to Characterize the Molecular and Immunophenotypic Heterogeneity of Human Stem and Progenitor Populations

Published on: October 25, 2018

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

Main Results:

Attendees' comprehension of biomarker roles in therapy was assessed.
Knowledge of key assays for biomarker measurement was evaluated.
Understanding of guideline-endorsed testing was reviewed.

Conclusions:

The session highlighted the importance of biomarker knowledge for oncologists.
Accurate biomarker testing is essential for effective targeted treatment selection.
Guideline adherence in biomarker testing optimizes patient outcomes.